Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population

Pediatrics

Volumn 130, Issue 5, 2012, Pages

  Vassy, Jason L ^a,b   DasMahapatra, Pronabesh ^c   Meigs, James B ^a,b   Schork, Nicholas J ^d   Magnussen, Costan G ^e,f   Chen, Wei ^c   Raitakari, Olli T ^g   Pencina, Michael J ^h   Jamal, Seema M ⁱ   Berenson, Gerald S ^c   Goodman, Elizabeth ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Tulane Center for Cardiovascular Health   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TASMANIA   (Australia)

^f UNIVERSITY OF TURKU   (Finland)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

^h Boston University   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent medicine; Diabetes mellitus; Genetic predisposition to disease; Type 2

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; CAUCASIAN; CHILD; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC SCREENING; GENOTYPE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADOLESCENT; AFRICAN AMERICANS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; PROGNOSIS;

EID: 84868618682     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1132     Document Type: Article

References (60)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information of Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011
2. Knowler WC, Barrett-Connor E, Fowler SE, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403 (Pubitemid 34437694)
3. Tuomilehto J, Lindström J, Eriksson JG, et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350 (Pubitemid 32378388)
4. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544
5. Zeggini E, Scott LJ, Saxena R, et al Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638-645 (Pubitemid 351601209)
6. Voight BF, Scott LJ, Steinthorsdottir V, et al; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579-589
7. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341-1345 (Pubitemid 46871655)
8. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41(10):1110-1115
9. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881-885
10. Saxena R, Voight BF, Lyssenko V, et al; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331-1336
11. Zeggini E, Weedon MN, Lindgren CM, et al Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336-1341 (Pubitemid 46871654)
12. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359(21):2208-2219
13. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359(21):2220-2232
14. van Hoek M, Dehghan A, Witteman JC, et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008;57(11):3122-3128
15. de Miguel-Yanes JM, Shrader P, Pencina MJ, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011;34(1):121-125
16. Berenson GS, McMahan CA, Voors AW, et al. Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY: Oxford University Press; 1980
17. Pickoff AS, Berenson GS, Schlant RC. Introduction to the symposium celebrating the Bogalusa Heart Study. Am J Med Sci. 1995;310(suppl 1):S1-S2
18. World Health Organization. Part 1: Diagnosis and Classi fication of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999. WHO/NCD/NCS/99.2
19. Franks PW, Hanson RL, Knowler WC, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56(12):2964-2972 (Pubitemid 350223631)
20. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Fasting plasma glucose levels within the normoglycemic range in childhood as a predictor of prediabetes and type 2 diabetes in adulthood: the Bogalusa Heart Study. Arch Pediatr Adolesc Med. 2010;164(2):124-128
21. Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Internal Med. 2007;167(10):1068-1074 (Pubitemid 46835795)
22. Morrison JA, Glueck CJ, Horn PS, Wang P. Childhood predictors of adult type 2 diabetes at 9- and 26-year follow-ups. Arch Pediatr Adolesc Med. 2010;164(1):53-60
23. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: Methods and Development. Hyattsville, MD: National Center for Health Statistics; 2002
24. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Kieltyka L, Berenson GS. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study. Diabetes Care. 2010;33(3):670-675
25. Smith EN, Chen W, Kähönen M, et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet . 2010;6(9):e1001094
26. Balkau B, Lange C, Fezeu L, et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2008;31(10):2056-2061
27. Sankararaman S, Sridhar S, Kimmel G, Halperin E. Estimating local ancestry in admixed populations. Am J Hum Genet. 2008;82(2):290-303 (Pubitemid 351726099)
28. Hosmer DW, Lemeshow S. A goodness-of-fit test for the multiple logistic regression model. Comm Stat. 1980;9(10):1043-1069
29. Pencina MJ, D 'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confi dence interval estimation. Stat Med. 2004;23(13):2109-2123
30. Pencina MJ, D' Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11-21
31. Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med. 2012;31(2):101-113
32. Hosmer DW, Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med. 1995;14(19):2161-2172
33. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575-581 (Pubitemid 34407041)
34. Schmidt MI, Duncan BB, Bang H, et al Atherosclerosis Risk in Communities Investigators. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(8):2013-2018 (Pubitemid 41060977)
35. Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ. 2010;340:b4838
36. Cooke JN, Ng MC, Palmer ND, et al. Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care. 2012;35(2):287-292
37. Waters KM, Stram DO, Hassanein MT, et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet. 2010;6(8):e1001078
38. Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000;49(12):2201-2207
39. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753
40. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth. 2009;9(6-7):3-10
41. Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, McBride CM. Parents' attitudes toward pediatric genetic testing for common disease risk. Pediatrics. 2011;127(5). Available at: www.pediatrics.org/cgi/content/full/127/ 5/e1288
42. National Society of Genetic Counselors. Position Statement: Prenatal and Childhood Testing for Adult-Onset Disorders. Chicago, IL: National Society of Genetic Counselors; 1995
43. Canadian Paediatric Society and Canadian College of Medical Geneticists. Guidelines for genetic testing of healthy children. Paediatr Child Health. 2003;8(1):42-45
44. European Society of Human Genetics. Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet. 2010;18(12):1271-1273
45. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Am J Hum Genet. 1995;57(5):1233-1241
46. Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107(6):1451-1455
47. European Society of Human Genetics. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2009;17(6):720-721
48. Foster GD, Linder B, Baranowski T, et al HEALTHY Study Group. A school-based intervention for diabetes risk reduction. N Engl J Med. 2010;363(5):443-453
49. Katz DL, O'Connell M, Njike VY, Yeh MC, Nawaz H. Strategies for the prevention and control of obesity in the school setting: systematic review and meta-analysis. Int J Obes (Lond). 2008;32(12):1780-1789
50. Rosenbaum M, Nonas C, Weil R, et al Camino Diabetes Prevention Group. School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. J Clin Endocrinol Metab. 2007;92(2):504-508
51. Whitlock EA, O'Connor EP, Williams SB, Beil TL, Lutz KW. Effectiveness of weight management programs in children and adolescents. Evid Rep Technol Assess (Full Rep). 2008;(170):1-308
52. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40(9):1092-1097
53. Grant SFA, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320-323
54. Gloyn AL, Weedon MN, Owen KR, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 2003;52(2):568-572 (Pubitemid 36173218)
55. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26(1):76-80
56. Dupuis J, Langenberg C, Prokopenko I, et al DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Hamsten A on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105-116
57. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39(8):977-983 (Pubitemid 47185170)
58. Winckler W, Weedon MN, Graham RR, et al. Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes. 2007;56(3):685-693 (Pubitemid 46348464)
59. Qi L, Cornelis MC, Kraft P, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19(13):2706-2715
60. Kong A, Steinthorsdottir V, Masson G, et al DIAGRAM Consortium. Parental origin of sequence variants associated with complex diseases. Nature. 2009;462(7275):868-874